NIH-funded research Sbir 2 grant

Elderly-friendly, interpretable brain-monitoring to guide anesthesia with a FDA-cleared EEG device

Official title: Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor

Funded at Pascall Systems, Incorporated · NIH-11419855 · Data updated 2026-11-12

A small FDA-cleared brain-monitoring system and new, easy-to-understand brain-state markers will help tailor anesthesia doses for older adults, especially those with Alzheimer’s disease and related dementias.

More General Anesthesia research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionPascall Systems, Incorporated
NIH-funded
Lab location1 site (Boston, UNITED STATES)
Project startSeptember 15, 2024
Project endMay 31, 2027
Funding year2026
Award (this year)$1,069,722
NIH project number5R44AG090247-03
Project IDNIH-11419855 on NIH RePORTER

Who could benefit from this research

Could help

Older adults (typically 65+) undergoing procedures with propofol anesthesia, including individuals with Alzheimer’s disease and related dementias.

Less likely to help

Patients not receiving propofol anesthesia or those without ADRD-related risk may see limited direct benefit.

What this research studies

This project focuses on using a wireless EEG-based monitor and two interpretable brain markers to guide anesthesia dosing in aging patients. It builds on prior work that developed the monitor and cleared it with the FDA, and now aims to personalize unconsciousness levels during propofol anesthesia for people 65 and older, including those with ADRD. The approach uses Alpha Modulation Index and Slow Frequency Modulation Index along with a patient-specific responsiveness algorithm to inform the clinician how much anesthetic to give to stay at the desired unconsciousness level. The goal is to reduce over-sedation and the resulting risk of postoperative delirium by providing clearer, patient-tailored brain state information. The project emphasizes practical clinical integration, usability for caregivers, and safety in the elderly dementia population.

Why it matters

Potential benefit: If successful, this could reduce postoperative delirium and improve safety for older adults undergoing surgery by guiding more precise anesthesia dosing.

How similar studies have gone: Previous efforts demonstrated a viable FDA-cleared brain monitor and novel brain-state markers, with this grant advancing patient-specific use in dementia-affected patients.

Where this research is happening

  • Pascall Systems, Incorporated
    Boston, United States
    Active

Researchers

  • Principal investigator: Le Mau, Tuan — Pascall Systems, Incorporated
  • Study coordinator: Le Mau, Tuan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.